Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia
Forty-seven patients diagnosed as clinically demented were imaged with 123I isopropylamphetamine (IMP). All of these patients also had a nuclear magnetic resonance (NMR) study. In those patients diagnosed as having senile dementia of the Alzheimer type a bilateral reduction in IMP uptake in the temporo-parieto-occipital region was always seen. The NMR appearances were normal in 64% of these sites. The IMP images of patients with multi-infarct dementia varied from normal to marked focal deficits. There was, however, a much closer agreement between the abnormalities seen on the IMP and NMR images. In alcoholic dementia no focal areas of reduced IMP uptake were seen, although the uptake was generally irregular. In both Korsakoff's psychosis and Huntington's chorea the IMP uptake pattern and the NMR study were normal.
- Research Organization:
- Univ. of Aberdeen, Scotland
- OSTI ID:
- 5232651
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions
Assessment of demented patients by dynamic SPECT of inhaled xenon-133
Related Subjects
AMPHETAMINES
UPTAKE
BRAIN
RADIOISOTOPE SCANNING
IODINE 131
DIAGNOSTIC USES
LABELLED COMPOUNDS
MENTAL DISORDERS
NUCLEAR MAGNETIC RESONANCE
PATIENTS
ANALEPTICS
AUTONOMIC NERVOUS SYSTEM AGENTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CENTRAL NERVOUS SYSTEM
CENTRAL NERVOUS SYSTEM AGENTS
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DRUGS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
MAGNETIC RESONANCE
NERVOUS SYSTEM
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIOISOTOPES
RESONANCE
SYMPATHOMIMETICS
USES
550601* - Medicine- Unsealed Radionuclides in Diagnostics